English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluDEXIS, a provider of digital imaging solutions for dentistry, has announced that its latest software offering, DTX Studio Clinic, has received FDA 510(k) clearance for artificial intelligence (AI) findings on 2D intraoral x-ray images. This makes it the first imaging solution to provide six types of pathological dental findings on periapical and bitewing intraoral radiographs and is fully integrated into on-premise imaging software.
New AI Capabilities
DTX Studio Clinic is an imaging acquisition, diagnosis, and treatment planning software and is part of the DTX Studio suite of products used by over 10,000 dental offices. With this new AI capability, clinicians can reportedly screen dental radiographs and annotate suspected areas of interest, supporting them in making informed decisions. These clinical conditions include caries, discrepancy at margin, root canal defects, periapical radiolucency, bone loss, and calculus.
Click to Visit website of India's Leading Manufacturer of World Class Dental Materials, Exported to 90+ Countries.
According to Amir Aghdaei, CEO of Envista, “DEXIS is empowering practices to embrace digital dentistry for improved efficiencies and predictable patient outcomes. With our newest release of DTX Studio Clinic, featuring enhanced built-in AI features like the pathological dental findings, practices now have an enhanced solution for their digital workflow—from diagnosis to treatment planning to delivery of care.”
Click to visit website: The All-in-one patient centric cloud solution for intelligent radiograph detection and diagnosis.
DEXIS’ Other FDA Clearances
In addition to this recent clearance, DEXIS has received several others over the past few years for its AI-powered functionalities. These include FDA clearance for its AI-driven 3D virtual tooth setup algorithm in 2017, automatic tooth position identification and automated sorting of full-mouth x-ray series in 2020, and fully automated mandibular nerve tracing on CBCT scans in 2022.
According to DEXIS, the integration of AI technology into dental imaging software is a promising development for dental professionals, as it can support more accurate and efficient diagnoses while also improving patient outcomes. With DEXIS’ latest clearance, clinicians can present patients with a more comprehensive view of their diagnosis and treatment plan, says the company, building patient understanding and trust while also driving practice efficiencies.
Click here for more information on the DTX Studio Clinic by DEXIS.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.